Home > PJ (current issue) > Products | Search
Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7258 p79
19 July 2003

This article
Reprint
Photocopy


Announcements

Announcements

Human insulin name changes

Novo Nordisk has announced that its range of human insulins is undergoing name and packaging changes between July and December to harmonise brand names throughout Europe. The name changes are as follows:

Current name

European standardised name

Actrapid Pen

Actrapid NovoLet

Human Insulatard Pen

Insulatard NovoLet

Human Mixtard 10 Pen

Mixtard 10 NovoLet

Human Mixtard 20 Pen

Mixtard 20 NovoLet

Human Mixtard 30 Pen

Mixtard 30 NovoLet

Human Mixtard 40 Pen

Mixtard 40 NovoLet

Human Mixtard 50 Pen

Mixtard 50 NovoLet

Human Actrapid (10ml vial)

Actrapid (10ml vial)

Human Insulatard ge (10ml vial)

Insulatard (10ml vial)

Human Mixtard 30 ge (10ml vial)

Mixtard 30 (10ml vial)

Human Mixtard 50 (10ml vial)

Mixtard 50 (10ml vial)

Human Velosulin (10 ml vial)

Velosulin (10ml vial)

Human Monotard (10ml vial)

Monotard (10ml vial)

Human Ultratard (10ml vial)

Ultratard (10ml vial)

Back to Top

Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal